MRI tracking of polyethylene glycol-coated superparamagnetic iron oxide-labelled placenta-derived mesenchymal stem cells toward glioblastoma stem-like cells in a mouse model

References

• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996.
   PubMed Web of Science ®Google Scholar
• Lathia JD, Mack SC, Mulkearns-Hubert EE, et al. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203–1217.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;01414:105–111.
   Google Scholar
• Regina A, Demeule M, Laplante A, et al. Multidrug resistance in brain tumors: roles of the blood-brain barrier. Cancer Metastasis Rev. 2001;20:13–25.
   PubMed Web of Science ®Google Scholar
• Woodworth GF, Dunn GP, Nance EA, et al. Emerging insights into barriers to effective brain tumor therapeutics. Front Oncol. 2014;4:126.
   PubMedGoogle Scholar
• Bao B, Ahmad A, Li Y, et al. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells. Expert Opin Ther Targets. 2012;16:1041–1054.
   PubMed Web of Science ®Google Scholar
• Bagó JR, Alfonso-Pecchio A, Okolie O, et al. Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma. Nat Commun. 2016;7:10593.
   PubMed Web of Science ®Google Scholar
• Zhang S, Xie R, Zhao T, et al. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes. Int J Oncol. 2014;45:1989–1996.
   PubMed Web of Science ®Google Scholar
• Theele DP, Schrimsher GW, Reier PJ. Comparison of the growth and fate of fetal spinal iso- and allografts in the adult rat injured spinal cord. Exp Neurol. 1996;142:128–143.
   PubMed Web of Science ®Google Scholar
• Grisendi G, Bussolari R, Veronesi E, et al. Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res. 2011;1:787–805.
   PubMed Web of Science ®Google Scholar
• Kim SM, Lim JY, Park SI, et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res. 2008;68:9614–9623.
   PubMed Web of Science ®Google Scholar
• Saei Arezoumand K, Alizadeh E, Pilehvar-Soltanahmadi Y, et al. An overview on different strategies for the stemness maintenance of MSCs. Artif Cells Nanomed Biotechnol. 2017;45:1255–1271.
   PubMed Web of Science ®Google Scholar
• Liu L, Eckert MA, Riazifar H, et al. From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? Stem Cells Int. 2013;2013:1.
   Web of Science ®Google Scholar
• Gao F, Chiu SM, Motan DAL, et al. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016;7:e2062.
   PubMed Web of Science ®Google Scholar
• Shi Y, Du L, Lin L, et al. Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov. 2017;16:35–52.
   PubMed Web of Science ®Google Scholar
• Kosztowski T, Zaidi HA, Quiñones-Hinojosa A. Applications of neural and mesenchymal stem cells in the treatment of gliomas. Expert Rev Anticancer Ther. 2009;9:597–612.
   PubMed Web of Science ®Google Scholar
• Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells. 2008;26:300–311.
   PubMed Web of Science ®Google Scholar
• Barlow S, Brooke G, Chatterjee K, et al. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev. 2008;17:1095–1107.
   PubMed Web of Science ®Google Scholar
• Brooke G, Tong H, Levesque JP, et al. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev. 2008;17:929–940.
   PubMed Web of Science ®Google Scholar
• Chambers DC, Enever D, Ilic N, et al. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology. 2014;19:1013–1018.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Bowen JD, Huddlestone J, et al. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Mult Scler Relat Disord. 2014;3:696–704.
   PubMed Web of Science ®Google Scholar
• Mayer L, Pandak WM, Melmed GY, et al. Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant Crohn's disease: a phase 1 study. Inflamm Bowel Dis. 2013;19:754–760.
   PubMed Web of Science ®Google Scholar
• Li X, Ling W, Pennisi A, et al. Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone. Stem Cells. 2011;29:263–273.
   PubMed Web of Science ®Google Scholar
• Chen Q, Cheng P, Song N, et al. Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model. Oncol Lett. 2012;4:413–418.
   PubMed Web of Science ®Google Scholar
• Zheng L, Zhang D, Chen X, et al. Antitumor activities of human placenta-derived mesenchymal stem cells expressing endostatin on ovarian cancer. PLoS One. 2012;7:e39119.
   PubMed Web of Science ®Google Scholar
• Frank JA, Anderson SA, Kalsih H, et al. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy. 2004;6:621–625.
   PubMed Web of Science ®Google Scholar
• Ariza de Schellenberger A, Kratz H, Farr TD, et al. Labeling of mesenchymal stem cells for MRI with single-cell sensitivity. Int J Nanomed. 2016;11:1517–1535.
   PubMed Web of Science ®Google Scholar
• Naseri N, Ajorlou E, Asghari F, et al. An update on nanoparticle-based contrast agents in medical imaging. Artif Cells Nanomed Biotechnol. 2018;46:1111–1121.
   PubMed Web of Science ®Google Scholar
• Jin R, Lin B, Li D, et al. Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol. 2014;18:18–27.
   PubMed Web of Science ®Google Scholar
• Wang YX. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg. 2011;1:35–40.
   PubMedGoogle Scholar
• Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004;17:484–499.
   PubMed Web of Science ®Google Scholar
• Henning TD, Boddington S, Daldrup-Link HE. Labeling hESCs and hMSCs with iron oxide nanoparticles for non-invasive in vivo tracking with MR imaging. J Vis Exp. 2008;13:e685.
   Google Scholar
• Khurana A, Nejadnik H, Chapelin F, et al. Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI. Nanomedicine (Lond). 2013;8:1969–1983.
   PubMed Web of Science ®Google Scholar
• Kitagawa F, Kubota K, Sueyoshi K, et al. One-step preparation of amino-PEG modified poly(methyl methacrylate) microchips for electrophoretic separation of biomolecules. J Pharm Biomed Anal. 2010;53:1272–1277.
   PubMed Web of Science ®Google Scholar
• Chao YC, Su SK, Lin YW, et al. Synthesis and application of polyethylene glycol/vinyltriethoxy silane (PEG/VTES) copolymers. Afr J Biotechnol. 2011;10:12754–12761.
   Google Scholar
• Ling D, Hackett MJ, Hyeon T. Surface ligands in synthesis, modification, assembly and biomedical applications of nanoparticles. Nano Today. 2014;9:457–477.
   Web of Science ®Google Scholar
• Shen R, Camargo PH, Xia Y, et al. Silane-based poly(ethylene glycol) as a primer for surface modification of nonhydrolytically synthesized nanoparticles using the Stober method. Langmuir. 2008;24:11189–11195.
   PubMed Web of Science ®Google Scholar
• Kasten A, Gruttner C, Kuhn JP, et al. Comparative in vitro study on magnetic iron oxide nanoparticles for MRI tracking of adipose tissue-derived progenitor cells. PLoS One. 2014;9:e108055.
   PubMed Web of Science ®Google Scholar
• Hu X, Wei L, Taylor TM, et al. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation. Am J Physiol Cell Physiol. 2011;301:C362–C372.
   PubMed Web of Science ®Google Scholar
• Pham K, Luo D, Liu C, et al. CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5. J Neuroimmunol. 2012;246:10–17.
   PubMed Web of Science ®Google Scholar
• Pan Y, Smithson LJ, Ma Y, et al. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival. Oncotarget. 2017;8:32977–32989.
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25:1737–1745.
   PubMed Web of Science ®Google Scholar
• Ringe J, Strassburg S, Neumann K, et al. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem. 2007;101:135–146.
   PubMed Web of Science ®Google Scholar
• Song CH, Honmou O, Furuoka H, et al. Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions. J Virol. 2011;85:11069–11078.
   PubMed Web of Science ®Google Scholar
• Deak E, Seifried E, Henschler R. Homing pathways of mesenchymal stromal cells (MSCs) and their role in clinical applications. Int Rev Immunol. 2010;29:514–529.
   PubMed Web of Science ®Google Scholar
• Miao Z, Jin J, Chen L, et al. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int. 2006;30:681–687.
   PubMed Web of Science ®Google Scholar
• Li G, Zhang XA, Wang H, et al. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics. 2009;9:20–30.
   PubMed Web of Science ®Google Scholar
• Ho IA, Chan KY, Ng WH, et al. Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells. 2009;27:1366–1375.
   PubMed Web of Science ®Google Scholar
• Ries C, Egea V, Karow M, et al. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood. 2007;109:4055–4063.
   PubMed Web of Science ®Google Scholar
• Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005;65:3307–3318.
   PubMed Web of Science ®Google Scholar
• Hata N, Shinojima N, Gumin J, et al. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery. 2010;66:144–156.
   PubMed Web of Science ®Google Scholar
• Thomas JG, Parker Kerrigan BC, Hossain A, et al. Ionizing radiation augments glioma tropism of mesenchymal stem cells. J Neurosurg. 2018;128:287–295.
   PubMed Web of Science ®Google Scholar
• Boltze J, Arnold A, Walczak P, et al. The dark side of the force - constraints and complications of cell therapies for stroke. Front Neurol. 2015;6:155.
   PubMed Web of Science ®Google Scholar
• Cui LL, Kerkela E, Bakreen A, et al. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cells Res Ther. 2015;6:11.
   PubMed Web of Science ®Google Scholar
• Ye J, Wu D, Wu P, et al. The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment. Tumour Biol. 2014;35:3945–3951.
   PubMedGoogle Scholar
• Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell. 2015;16:225–238.
   PubMed Web of Science ®Google Scholar
• Arbab AS, Frank JA. Cellular MRI and its role in stem cell therapy. Regen Med. 2008;3:199–215.
   PubMed Web of Science ®Google Scholar
• Wang Y-XJ, Quercy-Jouvet T, Wang H-H, et al. Efficacy and durability in direct labeling of mesenchymal stem cells using ultrasmall superparamagnetic iron oxide nanoparticles with organosilica, dextran, and PEG coatings. Materials. 2011;4:703–715.
   PubMed Web of Science ®Google Scholar